- Fund Type: Open-End Fund
- Objective: Sector Fund-Asset Allocation
- Asset Class: Asset Allocation
- Geographic Focus: India
Reliance Pharma Fund
+ Add to WatchlistRELPHRD:IN
45.95 INR 0.19 0.41%As of 00:59:30 ET on 05/17/2013.
Snapshot for Reliance Pharma Fund (RELPHRD)
| Year To Date: | +5.52% | 3-Month: | +12.96% | 3-Year: | +14.10% | 52-Week Range: | 37.52 - 47.64 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +7.94% | 1-Year: | +30.12% | 5-Year: | +24.56% | Beta vs BSETHC: | 0.99 |
Fund Profile & Information for RELPHRD
Reliance Pharma Fund is an open-ended fund incorporated in India. The Fund seeks to generate consistent returns by investing in equity and equity related instruments or fixed income securities of the companies that cater to any segment of the pharmaceutical chain. The Fund invests in the debt and money market instruments with an average maturity of five to ten years.
| Inception Date: | 05-26-2004 | Telephone: | 91-22-3099-4600 Tel |
|---|---|---|---|
| Managers: | SAILESH RAJ BHAN | ||
| Web Site: | www.reliancecapital.co.in | ||
Fundamentals for RELPHRD
| NAV | (on 2013-05-17) 45.95 |
|---|---|
| Assets (M) | (on 2013-04-30) 6,847.52 |
| Fund Leveraged | N |
| Minimum Investment | 10,000.00 |
| Minimum Subsequent Investment | 1.00 |
Dividends for RELPHRD
| Dividend Type | Distribution |
|---|---|
| Dividend Frequency | Irreg |
| Last Dividend Net | (on 2013-01-14) 3.50 |
| Dividend Yield (ttm) | 7.62 |
Fees & Expenses for RELPHRD
| Front Load | 2.25 |
|---|---|
| Back Load | 1.00 |
| Current Mgmt Fee | 1.07 |
| Redemption Fee | 1.00 |
| 12b1 Fee | 0.25 |
| Expense Ratio | 2.46 |
Top Fund Holdings for RELPHRD
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Divi's Laboratories Ltd | 700,000 | 752,395,000 | 10.988% |
| Ranbaxy Laboratories Ltd | 1,400,000 | 632,730,000 | 9.240% |
| Sanofi India Ltd | 245,810 | 628,167,000 | 9.174% |
| Cipla Ltd/India | 1,523,439 | 617,450,000 | 9.017% |
| Dr Reddy's Laboratories Ltd | 285,100 | 578,240,000 | 8.445% |
| Sun Pharma Advanced Research C | 3,906,291 | 484,575,000 | 7.077% |
| Sun Pharmaceutical Industries | 500,000 | 475,525,000 | 6.944% |
| GlaxoSmithKline Pharmaceutical | 187,900 | 425,086,000 | 6.208% |
| Indoco Remedies Ltd | 5,754,278 | 363,383,000 | 5.307% |
| Abbott India Ltd | 219,550 | 308,830,000 | 4.510% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page